RxDoctor Payments Data

Alissa Whittaker

Family · Plymouth, INNPI 1033540638

Payments from drug & device makers

$2,479in general payments, 2019–2025

Across 150 payments — averaging $16.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$376
  • Corium, LLC$235
  • Novo Nordisk$197
  • Tris Pharma Inc$176
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$128
  • Teva Pharmaceuticals USA, Inc.$126
  • plus $1K from 26 others

What the payments were for

  • Food & beverage$2,36896%
  • Education$1114%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,479 in reported general payments places this provider in the 80th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin11$10,224
Spiriva RespimatTiotropium Bromide12$6,204
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,606
Levothyroxine Sodium83$823
Propranolol Hcl23$790
Fenofibrate23$579
Duloxetine Hcl35$428
Gabapentin19$375
Metformin Hcl41$360
Famotidine35$359
Lisinopril54$274
Amlodipine Besylate81$257
Atorvastatin Calcium38$255
Albuterol Sulfate HfaAlbuterol Sulfate20$208
Tamsulosin Hcl17$200

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat$15$16,42823 claims
GSKAnoro Ellipta$112$5,60612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,392 family providers in Indiana.

Other family in Plymouth

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →